Evidence map›Paper›PMID 40459508›Full record

ArticleSmall methods2025

Self-Disassembling Macroporous Metal-Organic Framework-Based Micromotors with Magnetically Controlled Motion for Sequential Drug Release.

Javier Bujalance Fernández, Víctor de la Asunción-Nadal, Beatriz Jurado Sánchez, Alberto Escarpa

Abstract read
In one paragraph

Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Javier Bujalance FernándezDepartment of Analytical Chemistry, Physical Chemistry and Chemical Engineering, Universidad de Alcala, Alcala de Henares, Madrid, E-28802, Spain.ORCID https://orcid.org/0000-0002-4582-296X
Víctor de la Asunción-NadalDepartment of Analytical Chemistry, Physical Chemistry and Chemical Engineering, Universidad de Alcala, Alcala de Henares, Madrid, E-28802, Spain.ORCID https://orcid.org/0000-0001-6331-5219
Beatriz Jurado SánchezDepartment of Analytical Chemistry, Physical Chemistry and Chemical Engineering, Universidad de Alcala, Alcala de Henares, Madrid, E-28802, Spain.ORCID https://orcid.org/0000-0002-6584-1949
Alberto EscarpaDepartment of Analytical Chemistry, Physical Chemistry and Chemical Engineering, Universidad de Alcala, Alcala de Henares, Madrid, E-28802, Spain.ORCID https://orcid.org/0000-0002-7302-0948

Funding

Actuación Excelencia para el Profesorado Universitario de la EPU-INV-UAH/2022/00European Union "NextGenerationEU CNS2023-144653European Union "NextGenerationEU MCIN/AEI/10.13039/ 501100011033FEDER MCIN/AEI/10.13039/501100011033FEDER TED2021-132720B-I00Junta de Comunidades de Castilla-La Mancha SBPLY/23/180225/000058Universidad de Alcalá FPI UAH
6 · The paper itself

Abstract

Herein, the synthesis of macroporous zeolitic imidazole framework (ZIF)-based magnetic micromotors (MMs) for the dual encapsulation of 5-fluorouracil (5-FU) and doxorubicin (DOX), with pH-triggered release is described. The MMs are synthesized in methanolic solutions, using superparamagnetic iron oxide nanoparticles (Fe₃O₄) as seeding agents and magnetic engines. The macroporous structure facilitates the loading of high doses of 5-FU, while DOX is docked on the surface of the MMs. This results in release rates of 72.8 µg mg MMs⁻¹ of 5-FU and 3 µg mg MMs⁻¹ of DOX. The magnetic motion of the MMs enables targeted delivery to predefined locations, allowing interaction with cancer cells in the culture medium. Under acidic conditions, DOX becomes protonated and is released from the surface of the micromotors, demonstrating rapid-release kinetics. Simultaneously, the ZIF-8 structure degrades under these conditions, enabling the sustained release of 5-FU for continuous treatment. This dual-delivery, pH-induced mechanism is demonstrated in vitro using Caco-2 cells as a relevant biological model, revealing a decrease in viability and diffusion of the drugs released into the cells. This is the first magnetic metal-organic framework (MOF)-based MM that is pH-sensitive and capable of sequentially releasing two drugs.

Indexed as

5‐fluorouracilcancer cellsdeliverydoxorubicinzeolitic imidazole frameworks

Identifiers

PMID40459508
PMCPMC12536394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.